Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Tadekinig alfa

EU orphan designation number: EU/3/16/1763   
Active ingredient: Tadekinig alfa
Indication: Treatment of haemophagocytic lymphohistiocytosis
Sponsor: Coté Orphan Consulting UK Limited
c/o Elemental CoSec, 27 Old Gloucester Street, London WC1N 3AX, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/150/16 (2016)6755 of 14/10/2016